Fourteen weeks of liraglutide therapy in subjects with type 2 diabetes significantly improves first phase insulin secretion and maximal beta-cell secretory capacity

被引：0
|
作者：
Madsbad, S.
Brock, B.
Perrild, H.
Lervang, H. H.
Kolendorf, K.
Krarup, T.
Schmitz, O.
Le-Thi, T.
Zdravkovic, M.
Vilsboll, T.
机构：
[1] Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark
[2] Aarhus Univ Hosp, Aarhus, Denmark
[3] Bispebjerg Univ Hosp, Copenhagen, Denmark
[4] Aarhus Univ Hosp, Aalborg, Denmark
[5] Roskilde Cty Psychiat Hosp Fjorden, Roskilde, Denmark
[6] Gentofte Univ Hosp, Hellerup, Denmark
[7] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0004
引用
收藏
页码：4 / 5
页数：2
相关论文
共 50 条
  • [31] High-Intensity Interval Training Improves Insulin Sensitivity but Not Beta-Cell Function Indices in Patients with Type 2 Diabetes
    Apostolopoulou, Maria
    Pacini, Giovanni
    Roehling, Martin
    Muessig, Karsten
    Szendroedi, Julia
    Roden, Michael
    DIABETES, 2016, 65 : A190 - A190
  • [32] Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes
    Retnakaran, Ravi
    Pu, Jiajie
    Emery, Alexandra
    Harris, Stewart B.
    Reichert, Sonja M.
    Gerstein, Hertzel C.
    McInnes, Natalia
    Kramer, Caroline K.
    Zinman, Bernard
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [33] Robust Arginine-Stimulated Glucagon Secretion in Patients with Type 1 Diabetes Independent of Diabetes Duration, Age, HbA1c, and Beta-Cell Secretory Capacity
    Warnoe, Julie
    Johansen, Nicklas J.
    Lund, Asger
    Bagger, Jonatan I.
    Albrechtsen, Nicolai J. Wewer, Sr.
    Hartmann, Bolette
    Holst, Jens J.
    Vilsboll, Tina
    Andersen, Henrik U.
    Dejgaard, Thomas F.
    Knop, Filip K.
    DIABETES, 2021, 70
  • [34] Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes
    Ravi Retnakaran
    Jiajie Pu
    Alexandra Emery
    Stewart B. Harris
    Sonja M. Reichert
    Hertzel C. Gerstein
    Natalia McInnes
    Caroline K. Kramer
    Bernard Zinman
    Nature Communications, 14
  • [35] Continuous Subcutaneous Insulin Infusion Therapy Increased Beta-Cell Function for One Year in Type 2 Diabetes Patients
    Hong, Eun Shil
    Choi, Soo Bong
    An, Hyun Ju
    Noh, Yun H.
    DIABETES, 2017, 66 : A279 - A279
  • [36] Insulin detemir significantly improves glycemic control over 52 weeks without affecting hypoglycemia in insulin-naive subjects with type 2 diabetes previously treated with OADs
    Pinget, Michel
    Fontaine, Pierre
    Gonbert, Sophie
    Hansen, Jes B.
    DIABETES, 2008, 57 : A579 - A579
  • [37] Nine weeks of bedtime diazoxide is well tolerated and beta-cell beneficial in subjects with type 2 diabetes (vol 21, pg 73, 2004)
    不详
    DIABETIC MEDICINE, 2008, 25 (02) : 243 - 243
  • [38] DIETARY-TREATMENT IMPROVES BETA-CELL RESPONSIVENESS TO ORAL GLUCOSE IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES
    KENNEDY, L
    WALSHE, K
    STEWART, D
    ATKINSON, AB
    BUCHANAN, KD
    HADDEN, DR
    DIABETOLOGIA, 1984, 27 (02) : A295 - A295
  • [39] BETA-CELL CYTOADHERENT LYMPHOCYTES IN SOME SUBJECTS AT RISK FOR TYPE-1 (INSULIN-DEPENDENT) DIABETES - PROGRESSION TO DIABETES WITHIN 2 YEARS
    BARDET, S
    ROHMER, V
    MAUGENDRE, D
    VALENTIN, A
    GALLOIS, Y
    STETIEH, H
    MARRE, M
    ALLANNIC, H
    CHARBONNEL, B
    SAI, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (05): : 1310 - 1317
  • [40] Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus
    Kanauchi, M
    Nakajima, M
    Saito, Y
    Kanauchi, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (04): : 476 - 481
12345